Clinical and echocardiographic characteristics of elderly hospitalized patients with high levels of NT-proBNP without clinical diagnosis of heart failure

Aging Clinical and Experimental Research

Volumn 26, Issue 6, 2014, Pages 607-613

  Lelli, D ^a   Pedone, C ^a,b   Rossi, F F ^a   Antonelli Incalzi, R ^a,c  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b Fondazione Alberto Sordi   (Italy)

^c Fondazione ‘San Raffaele Cittadella della Carità’ ^*  (Italy)

Author keywords

Elderly; Heart disease; Heart failure; NT proBNP

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; HEMOGLOBIN; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

AGED; BLOOD; CARDIOVASCULAR SYSTEM; COMORBIDITY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; MALE; METABOLISM; PATHOLOGY; UREA NITROGEN BLOOD LEVEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD UREA NITROGEN; CARDIOVASCULAR SYSTEM; COMORBIDITY; CREATININE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEMOGLOBINS; HOSPITALIZATION; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS;

EID: 84935473350     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/s40520-014-0226-y     Document Type: Article

References (27)

1. Kannel WB (1999) Current status of the epidemiology of heart failure. Curr Cardiol Rep 1: 11-19.
2. Yousaf F, Collerton J, Kingston A, Kenny A, Davies K, Jagger C, Robinson L, Kirkwood TBL, Keavney B (2012) Prevalence of left ventricular dysfunction in a UK community sample of very old people: the Newcastle 85? study. Heart Br Card Soc 98: 1418-1423. doi: 10. 1136/heartjnl-2012-302457.
3. Hobbs FDR, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK (2002) Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 23: 1867-1876.
4. Masoudi FA, Rumsfeld JS, Havranek EP, House JA, Peterson ED, Krumholz HM, Spertus JA (2004) Age, functional capacity, and health-related quality of life in patients with heart failure. J Card Fail 10: 368-373.
5. Massie BM, Shah NB (1997) Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 133: 703-712.
6. Masoudi FA, Havranek EP, Krumholz HM (2002) The burden of chronic congestive heart failure in older persons: magnitude and implications for policy and research. Heart Fail Rev 7: 9-16.
7. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B (2005) ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the heart rhythm society. Circulation 112: 154-235. doi: 10. 1161/CIRCULATIONAHA. 105. 167586.
8. McGrath MF, de Bold MLK, de Bold AJ (2005) The endocrine function of the heart. Trends Endocrinol Metab TEM 16: 469-477. doi: 10. 1016/j. tem. 2005. 10. 007.
9. McKie PM, Cataliotti A, Sangaralingham SJ, Ichiki T, Cannone V, Bailey KR, Redfield MM, Rodeheffer RJ, Burnett JC Jr (2011) Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up study. Mayo Clin Proc Mayo Clin 86: 1154-1160. doi: 10. 4065/mcp. 2011. 0437.
10. deFilippi CR, Christenson RH, Gottdiener JS, Kop WJ, Seliger SL (2010) Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing. J Am Coll Cardiol 55: 441-450. doi: 10. 1016/j. jacc. 2009. 07. 069.
11. Oudejans I, Mosterd A, Bloemen JA, Valk MJ, van Velzen E, Wielders JP, Zuithoff NP, Rutten FH, Hoes AW (2011) Clinical evaluation of geriatric outpatients with suspected heart failure: value of symptoms, signs, and additional tests. Eur J Heart Fail 13: 518-527. doi: 10. 1093/eurjhf/hfr021.
12. Frankenstein L, Clark AL, Goode K, Ingle L, Remppis A, Schellberg D, Grabs F, Nelles M, Cleland JGF, Katus HA, Zugck C (2009) The prognostic value of individual NT-proBNP values in chronic heart failure does not change with advancing age. Heart Br Card Soc 95: 825-829. doi: 10. 1136/hrt. 2008. 158626.
13. Cleland JGF, Taylor J, Freemantle N, Goode KM, Rigby AS, Tendera M (2012) Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study. Eur J Heart Fail 14: 487-494. doi: 10. 1093/eurjhf/hfs049.
14. Hinderliter AL, Blumenthal JA, O'Conner C, Adams KF, Dupree CS, Waugh RA, Bensimhon D, Christenson RH, Sherwood A (2008) Independent prognostic value of echocardiography and N-terminal pro-B-type natriuretic peptide in patients with heart failure. Am Heart J 156: 1191-1195. doi: 10. 1016/j. ahj. 2008. 07. 022.
15. Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, Pedersen F (2003) The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart Br Card Soc 89: 745-751.
16. Costello-Boerrigter LC, Boerrigter G, Redfield MM, Rodeheffer RJ, Urban LH, Mahoney DW, Jacobsen SJ, Heublein DM, Burnett JC Jr (2006) Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 47: 345-353. doi: 10. 1016/j. jacc. 2005. 09. 025.
17. Lien CTC, Gillespie ND, Struthers AD, McMurdo MET (2002) Heart failure in frail elderly patients: diagnostic difficulties, comorbidities, polypharmacy and treatment dilemmas. Eur J Heart Fail 4: 91-98.
18. DeFilippi C, van Kimmenade RRJ, Pinto YM (2008) Aminoterminal pro-B-type natriuretic peptide testing in renal disease. Am J Cardiol 101: 82-88. doi: 10. 1016/j. amjcard. 2007. 11. 029.
19. Manzano L, Escobar C, Cleland JGF, Flather M (2012) Diagnosis of elderly patients with heart failure. Eur J Heart Fail 14: 1097-1103. doi: 10. 1093/eurjhf/hfs109.
20. Zaphiriou A, Robb S, Murray-Thomas T, Mendez G, Fox K, McDonagh T, Hardman SMC, Dargie HJ, Cowie MR (2005) The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study. Eur J Heart Fail 7: 537-541. doi: 10. 1016/j. ejheart. 2005. 01. 022.
21. Januzzi JL Jr, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, Tung R, Cameron R, Nagurney JT, Chae CU, Lloyd-Jones DM, Brown DF, Foran-Melanson S, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB (2005) The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95: 948-954. doi: 10. 1016/j. amj card. 2004. 12. 032.
22. Nadir MA, Rekhraj S, Wei L, Lim TK, Davidson J, MacDonald TM, Lang CC, Dow E, Struthers AD (2012) Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease. J Am Coll Cardiol 60: 960-968. doi: 10. 1016/j. jacc. 2012. 04. 049.
23. Kalogeropoulos AP, Georgiopoulou VV, deFilippi CR, Gottdiener JS, Butler J (2012) Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the cardiovascular health study. JACC Cardiovasc Imaging 5: 131-140. doi: 10. 1016/j. jcmg. 2011. 11. 011.
24. Carlsen CM, Bay M, Kirk V, Gøtze JP, Køber L, Nielsen OW (2012) Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital heart failure study. Eur J Heart Fail 14: 240-247. doi: 10. 1093/eurjhf/hfs003.
25. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350: 655-663. doi: 10. 1056/NEJMoa031994.
26. Murtagh G, Dawkins IR, O'Connell R, Badabhagni M, Patel A, Tallon E, O'Hanlon R, Ledwidge MT, McDonald KM (2012) Screening to prevent heart failure (STOP-HF): expanding the focus beyond asymptomatic left ventricular systolic dysfunction. Eur J Heart Fail 14: 480-486. doi: 10. 1093/eurjhf/hfs030.
27. deFilippi CR, Christenson RH, Kop WJ, Gottdiener JS, Zhan M, Seliger SL (2011) Left ventricular ejection fraction assessment in older adults: an adjunct to natriuretic peptide testing to identify risk of new-onset heart failure and cardiovascular death? J Am Coll Cardiol 58: 1497-1506. doi: 10. 1016/j. jacc. 2011. 06. 042.